Fatigue in Patients with Sarcoidosis in Denmark
- PMID: 36773043
- DOI: 10.1007/s00408-023-00602-0
Fatigue in Patients with Sarcoidosis in Denmark
Abstract
Introduction: Sarcoidosis is a systemic granulomatous disease of unknown etiology, primarily affecting the lungs and thoracic lymph nodes. Fatigue is a frequent and disabling symptom in sarcoidosis with a significant impact on quality of life. In Denmark, the incidence of sarcoidosis has increased; however, the extent and risk factors of fatigue have not been investigated and no recent reports of the characteristics of patients with sarcoidosis in Denmark exist.
Aim: To assess the frequency of fatigue in patients with sarcoidosis in Denmark at diagnosis and to investigate if fatigue correlated with relevant disease parameters. Moreover, to characterize patients with sarcoidosis in Denmark at time of diagnosis.
Methods: Data were collected in 150 patients with recently diagnosed sarcoidosis. Fatigue was measured using the Fatigue Assessment Scale (FAS). Patients with fatigue were compared to non-fatigue patients regarding clinical parameters.
Results: FAS was completed by 145 of 150 patients. Fifty-one percent reported significant fatigue. Mean FAS score was 23.6 and 51% had a FAS score ≥ 22. Fatigue in 89 incident patients did not correlate significantly with demographics, physiological, or clinical parameters. Fifty-nine percent were males. Mean age was 47 years; mean values (% predicted) for pulmonary function tests were normal and 71% at Scadding stage 0-I.
Conclusion: In Denmark, fatigue was frequent in patients with sarcoidosis. The majority of patients had mild disease at diagnosis and were older but lower at Scadding stage at diagnosis compared to previous cohorts.
Keywords: Fatigue; Granulomatous; Pulmonary; Sarcoidosis.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids.Sarcoidosis Vasc Diffuse Lung Dis. 2016 Aug 1;33(2):124-9. Sarcoidosis Vasc Diffuse Lung Dis. 2016. PMID: 27537714
-
Fatigue in patients with inactive sarcoidosis does not correlate with lung ventilation ability or walking distance. Pilot Study.Pneumonol Alergol Pol. 2015;83(1):14-22. doi: 10.5603/PiAP.2015.0002. Pneumonol Alergol Pol. 2015. PMID: 25577529
-
The relationship between fatigue and clinical parameters in pulmonary sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis. 2004 Jun;21(2):127-36. Sarcoidosis Vasc Diffuse Lung Dis. 2004. PMID: 15281434
-
The Fatigue Assessment Scale: quality and availability in sarcoidosis and other diseases.Curr Opin Pulm Med. 2018 Sep;24(5):495-503. doi: 10.1097/MCP.0000000000000496. Curr Opin Pulm Med. 2018. PMID: 29889115 Review.
-
[Many faces of sarcoidosis].Radiologe. 2016 Jan;56(1):77-88; quiz 89. doi: 10.1007/s00117-015-0063-9. Radiologe. 2016. PMID: 26732655 Review. German.
Cited by
-
LUNG Year in Review: 2023.Lung. 2024 Feb;202(1):1-4. doi: 10.1007/s00408-024-00671-9. Epub 2024 Feb 2. Lung. 2024. PMID: 38305892 No abstract available.
-
Longitudinal validation of King's Sarcoidosis Questionnaire in a prospective cohort with mild sarcoidosis.ERJ Open Res. 2024 Nov 11;10(6):00160-2024. doi: 10.1183/23120541.00160-2024. eCollection 2024 Nov. ERJ Open Res. 2024. PMID: 39534770 Free PMC article.
-
Angiotensin-converting enzyme genotypes and sarcoidosis: Correlation with susceptibility, progression and treatment response.Sarcoidosis Vasc Diffuse Lung Dis. 2025 Jun 25;42(2):16324. doi: 10.36141/svdld.v42i2.16324. Sarcoidosis Vasc Diffuse Lung Dis. 2025. PMID: 40699494 Free PMC article.
-
Evaluating fatigue and excessive daytime sleepiness: a comparative analysis of prevalence and correlating factors in interstitial lung disease patients and healthy controls.Ann Med. 2024 Dec;56(1):2398729. doi: 10.1080/07853890.2024.2398729. Epub 2024 Dec 3. Ann Med. 2024. PMID: 39624966 Free PMC article.
References
-
- Arkema EV, Grunewald J, Kullberg S et al (2016) Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. European Respir J 48:1690–1699. https://doi.org/10.1183/13993003.00477-2016 - DOI
-
- Sikjær MG, Hilberg O, Ibsen R, Løkke A (2021) Sarcoidosis: a nationwide registry-based study of incidence, prevalence and diagnostic work-up. Respir Med. https://doi.org/10.1016/j.rmed.2021.106548 - DOI - PubMed
-
- Darlington P, Gabrielsen A, Sörensson P et al (2014) HLA-alleles associated with increased risk for extra-pulmonary involvement in sarcoidosis. Tissue Antigen 83:267–272. https://doi.org/10.1111/TAN.12326 - DOI
-
- Grunewald J, Brynedal B, Darlington P et al (2010) Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients. Respir Res 11:1. https://doi.org/10.1186/1465-9921-11-25 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous